The role of PSMC4 in non-small cell lung cancer: implications for prognosis, diagnosis, and immune microenvironment modulation
IntroductionNon-small cell lung cancer (NSCLC) remains a principal cause of cancer-related mortality. The discovery of novel biomarkers is pivotal for enhancing early diagnosis, refining prognostic evaluations, and optimizing targeted therapeutic strategies. Proteasome 26S subunit ATPase 4 (PSMC4),...
Saved in:
| Main Authors: | Lili Zhu, Yuanjun Li, Yunfei Xu, Jian Lei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1503466/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proteasome subunit PSMC3 variants cause neurosensory syndrome combining deafness and cataract due to proteotoxic stress
by: Ariane Kröll‐Hermi, et al.
Published: (2020-06-01) -
A 23-gene multi-omics signature predicts prognosis and treatment response in non-small cell lung cancer
by: Yinxu Zhang, et al.
Published: (2025-07-01) -
Mast cells in lung of rat
by: I. Ivanova
Published: (2017-09-01) -
The Effects Of Tumor Localization On Small Cell Lung Cancer And Its Association With Prognosis
by: Sertan Bulut, et al.
Published: (2022-03-01) -
Analysis of the prognostic and immune role of MCM6 in pan-cancer and experimental validation in lung adenocarcinoma cells
by: Minghua Liao, et al.
Published: (2025-08-01)